Gilead Sciences Inc - Company & Market Research Reports

Home /
Companies /
Gilead Sciences Inc

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 166
Infectious Diseases Drugs 125
Genomics 102
Liver and Kidney Disorders Drugs 69
Immune Disorders Drugs 60
Drug Discovery 55
Pharmaceuticals 53
Cardiovascular Drugs 47
Biopharmaceuticals 44
Biotechnology 41
Leukemia Drugs 37
HIV/AIDS Drugs 36
Clinical Trials 31
Lymphoma Drugs 30
Respiratory Drugs 29
Allergy and Immunology 28
Musculoskeletal Disorders Drugs 27
Enzymes 26
Pulmonary Medicine 23
Oncology 21
Central Nervous System Drugs 20
Infusions and Injectables 19
Drug Delivery 19
Pharmaceutical Manufacturing 19
Gastrointestinal Drugs 13
Infectious Disease Testing 12
Vaccines 12
Endocrine and Metabolic Disorders Drugs 11
Healthcare Services 10
Diagnostics 10
Hematology 10
Hematological Drugs 10
Sexual and Reproductive Health Drugs 10
Antibiotics 9
Pharmaceutical Intermediates 8
Therapeutic Area 8
Optical Disorders Drugs 8
Breast Cancer Drugs 8
Stem Cells 8
Women's Health 7
Drugs by Therapeutic Area 6
Company Reports 5
Hepatology 5
Lung Cancer Drugs 5
Colon Cancer Drugs 5
Analgesics 5
Needles and Syringes 5
Nanomedicine 5
Liver Cancer Drugs 4
Cervical Cancer Drugs 4
Bladder Cancer Drugs 4
Anesthetic Drugs 4
Biomarkers 4
Dermatology 4
Skin Cancer Drugs 4
Dermatological Drugs 4
Immunosuppressive Drugs 4
Addiction Disorders Drugs 3
Generic Drugs 3
Prostate Cancer Drugs 3
Dental 3
Optical 3
Medical Devices 3
Over the Counter (OTC) Drugs 3
Mental Disorders Drugs 3
Biosimilars and Biosuperiors 3
Pediatrics 3
E-Healthcare 2
Pharmacoeconomics 2
Ovarian Cancer Drugs 2
Brain Cancer Drugs 2
In Vitro Diagnostics 2
Cancer Vaccines 2
Kidney Cancer Drugs 2
Vitamins and Dietary Supplements 2
Laboratory Equipment 2
Gastroenterology 2
Cardiology 2
Urological Disorders Drugs 2
Animal Pharmaceuticals 1
Neurology 1
Urology and Nephrology 1
Fertility Services 1
Proteomics 1
Cardiovascular Devices 1
Home Testing and Home Healthcare 1
Healthcare 1
Managed Care 1
Transdermal and Transmucosal Drug Delivery 1
Inhalers and Nebulisers 1
Blood Banking 1
Hospital Management 1
Surgical Procedures 1
Pancreatic Cancer Drugs 1
Thyroid Cancer Drugs 1
Uterine Cancer Drugs 1
Anatomy 1
Endocrinology 1
Alzheimer's Disease Drugs 1
Asthma Drugs 1
Bronchitis Drugs 1
Schizophrenia Drugs 1
Psoriasis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

1,042 Results (Page 26 of 53)
- Relevance
  Sort by

Leukemia Targeted Therapy Drugs Market - Global Forecast 2025-2030

 Report
August 2025
186 Pages
Global

From

€3166EUR$3,545USD£2,771GBP

€3518EUR$3,939USD£3,079GBP

Myelodysplastic Syndrome Drug Market - Global Forecast 2025-2030

 Report
August 2025
189 Pages
Global

From

€3166EUR$3,545USD£2,771GBP

€3518EUR$3,939USD£3,079GBP

Basal Cell Carcinoma Treatment Market Report 2025

 Report
March 2025
200 Pages
Global

From

€4010EUR$4,490USD£3,510GBP

Acute Myeloid Leukemia - Pipeline Insight, 2025

 Clinical Trials
April 2025
240 Pages
Global

From

€2143EUR$2,400USD£1,876GBP

€2679EUR$3,000USD£2,345GBP

Diffuse Large B-cell Lymphoma Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

 Report
March 2025
183 Pages
Global

From

€4019EUR$4,500USD£3,517GBP

NEED HELP FINDING THE RIGHT PRODUCT? Hoseok will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Head and Neck Squamous Cell Carcinoma - Global Strategic Business Report

 Report
November 2025
917 Pages
Global

From

€5224EUR$5,850USD£4,573GBP

Esophageal Squamous Cell Carcinoma Market - Global Strategic Business Report

 Report
November 2025
275 Pages
Global

From

€5224EUR$5,850USD£4,573GBP

Breast Adenocarcinoma Treatment - Global Strategic Business Report

 Report
November 2025
294 Pages
Global

From

€5224EUR$5,850USD£4,573GBP

Halothane Market - Global Forecast to 2030

 Report
August 2025
183 Pages
Global

From

€3166EUR$3,545USD£2,771GBP

€3518EUR$3,939USD£3,079GBP

Stem Cell Therapy Market - Global Forecast 2025-2032

 Report
November 2025
186 Pages
Global

From

€3166EUR$3,545USD£2,771GBP

€3518EUR$3,939USD£3,079GBP

Autoimmune Collaboration and Licensing Deals 2016-2025

 Report
October 2025
500 Pages +
Global

From

€3568EUR$3,995USD£3,123GBP

Cystic Fibrosis Therapeutics - Global Strategic Business Report

 Report
November 2025
282 Pages
Global

From

€5224EUR$5,850USD£4,573GBP

Waldenstrom Macroglobulinemia - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1429EUR$1,600USD£1,251GBP

€1786EUR$2,000USD£1,563GBP

B-Cell Non-Hodgkin Lymphoma - Pipeline Insight, 2025

 Clinical Trials
April 2025
240 Pages
Global

From

€2143EUR$2,400USD£1,876GBP

€2679EUR$3,000USD£2,345GBP

Leukemia Therapeutics Market Report 2025

 Report
September 2025
250 Pages
Global

From

€4010EUR$4,490USD£3,510GBP

Multiple Myeloma Drugs Market Report 2025

 Report
September 2025
250 Pages
Global

From

€4010EUR$4,490USD£3,510GBP

Leukemia Therapeutics Market Analysis & Forecast to 2024-2034

 Report
January 2024
200 Pages
Global

From

€3706EUR$4,150USD£3,244GBP

Hairy Cell Leukemia Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F

 Report
April 2025
183 Pages
Global

From

€4019EUR$4,500USD£3,517GBP

US General Anesthesia Drugs Market by Route of Administration (Intravenous, Inhalational) and End-user (Hospitals, Ambulatory Surgery Centers) - Forecast to 2025

 Report
February 2021
117 Pages
United States

From

€4420EUR$4,950USD£3,869GBP

Triple Negative Breast Cancer (TNBC) - Market Insight, Epidemiology And Market Forecast - 2032

 Report
November 2023
224 Pages
Global

From

€5358EUR$6,000USD£4,690GBP

€6698EUR$7,500USD£5,862GBP

1,042 Results (Page 26 of 53)
- 1
- 24
- 25
- 26
- 27
- 28

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.